|
|
|
Agenda: Day Three
Wednesday, June 9, 2004
|
8:00 a.m. |
Introduction to Day III
Anthony Farino
Partner and Leader
Global Pharmaceutical Advisory Services Group
PricewaterhouseCoopers LLP
Chicago, IL
(Colloquium Co chair)
|
8:15 a.m. |
Reflections on the Future of the Global Pharmaceutical Enterprise
P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman
Merck & Co.
Bedminister, NJ
|
8:35 a.m. |
The Public Perception of the Pharma, Biotech and Device Sectors
Humphrey Taylor
Chairman, Harris Poll and Harris Interactive
Chairman, National Council on Public Polls
Rochester, NY
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
9:15 a.m. |
Strategic Perspectives on the Future of the Biopharmaceutical Enterprise
Cavan Redmond
Executive Vice President and General Manager
BioPharma Business Unit
Wyeth Pharmaceuticals
Collegeville, PA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
9:45 a.m. |
The Role of the Medical Device Sector in Transforming American Healthcare
Blair Childs
Executive Vice President
Strategic Planning and Implementation
Advanced Medical Technology Association (AdvaMed)
Washington, DC
|
10:15 a.m. |
Break
|
10:45 a.m. |
The Strategic Implications of the New Medicare Prescription Drug Legislation
G. Lawrence Atkins, Ph.D.
Senior Director, Public Policy and Reimbursement
Schering-Plough Corporation
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Patricia M. Danzon, Ph.D.
Celia Z. Moh Professor; Professor of Health Care Systems and Insurance and Risk Management
Wharton School, University of Pennsylvania
Author, Pharmaceutical Price Regulation: National Policies vs. Global Interests
Philadelphia, PA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Ian Spatz
Vice President, Public Policy
Merck & Co., Inc.
Washington, DC
John K. Iglehart
Founding Editor, Health Affairs
National Correspondent, New England Journal of Medicine
Washington, DC
(Moderator)
|
12:00 noon |
Networking Luncheon
|
12:45 p.m. |
Introduction to Afternoon of Day III
Karen Williams
President, National Pharmaceutical Council
Reston, VA
(Colloquium Co chair)
|
1:00 p.m. |
Department of Justice Update regarding the Prosecution of Pharma, Biotech and Device Cases
Robert D. McCallum, Jr., Esq.
Associate Attorney General
United States Department of Justice
Washington, DC
|
1:45 p.m. |
Implementing the New Medicare Prescription Drug Legislation
Mark B. McClellan, MD, PhD
Administrator, Centers for Medicare & Medicaid Services
Washington, DC
|
2:30 p.m. |
Future Trends in American Health Care: How good for Pharma, Biotech and Device Manufacturers?
Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy
Woodrow Wilson School, Princeton University
Princeton, NJ
|
3:30 p.m. |
Colloquium Adjournment
|
|
